RTT NewsLilly’s Cyramza fails in liver cancer trialReuters(Reuters) – Eli Lilly and Co’s recently approved stomach cancer drug Cyramza failed to prolong the lives of patients with advanced liver cancer in a late-stage trial, the drugmaker said on Wednesday. Patients enrolled in the trial previously had failed to benefit …Lilly’s Cyramza Fails Phase III Trial in Liver CancerGenetic Engineering NewsLilly’s Cyramza Misses Primary Goal in Liver Cancer StudyWall Street JournalEli Lilly’s Liver Cancer Trial With Cyramza Fails To Meet Primary EndpointRTT NewsMarket News Call -MarketWatch -FierceBiotechall 15 news articles …Read Full Story
Lilly's Cyramza fails in liver cancer trial - Reuters
Real Estate of Cebu
